Genesys Hurley Cancer Inst Flint, MI - 48503

Genesys Hurley Cancer Inst is categorized under Oncologists in Flint, MI and active since 1999.

Genesys Hurley Cancer Inst was established in 1999, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Robert Giffel, Executive Director at the company’s single location by writing to 302 Kensington Avenue, Flint, Michigan MI 48503 or by phoning (810) 762-8226. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genesys Hurley Cancer Inst
Contact Person: Robert Giffel, Executive Director
Address: 302 Kensington Avenue, Flint, Michigan 48503
Phone Number: (810) 762-8226
Website Address: ghci.org
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Genesys Hurley Cancer Inst was started in 1999 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Robert Giffel, Executive Director for inquiries that concern Genesys Hurley Cancer Inst by calling the company number (810) 762-8226, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesys Hurley Cancer Inst can be found at the coordinates 43.02417,-83.66915 as well as the street address 302 Kensington Avenue in Flint, Michigan 48503.

For its online presence, you may visit Genesys Hurley Cancer Inst’s website at ghci.org and engage with its social media outlets through on Twitter and on Facebook.